A Rare Case of Hyperandrogenism Due to Fibrothecoma and Leydig Cell Tumor in a Postmenopausal Woman With Adrenal Adenoma: A Case Report and Literature Review

[1]  E. Adashi,et al.  Hyperthecosis: an underestimated nontumorous cause of hyperandrogenism , 2021, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[2]  G. Bifulco,et al.  Tolerability considerations for gonadotropin-releasing hormone analogues for endometriosis , 2020, Expert opinion on drug metabolism & toxicology.

[3]  R. Quinton,et al.  Clinical Case Seminar: Postmenopausal androgen excess–challenges in diagnostic work‐up and management of ovarian thecosis , 2018, Clinical endocrinology.

[4]  B. Mendonca,et al.  Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies. , 2017, European journal of endocrinology.

[5]  Longwen Chen,et al.  Sertoli-Leydig cell tumor with heterologous element: a case report and a review of the literature. , 2014, International journal of clinical and experimental pathology.

[6]  B. Velkeniers,et al.  Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases , 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[7]  H. Escobar-Morreale,et al.  Management of postmenopausal virilization. , 2012, The Journal of clinical endocrinology and metabolism.

[8]  M. Rothman,et al.  How should postmenopausal androgen excess be evaluated? , 2011, Clinical endocrinology.

[9]  G. Chrousos,et al.  Hyperandrogenism in women with polycystic ovary syndrome persists after menopause. , 2011, The Journal of clinical endocrinology and metabolism.

[10]  A. V. van Beek,et al.  Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin. , 2011, The Journal of clinical endocrinology and metabolism.

[11]  Y. Asmann,et al.  Effect of Testosterone on Insulin Stimulated IRS1 Ser Phosphorylation in Primary Rat Myotubes—A Potential Model for PCOS-Related Insulin Resistance , 2009, PloS one.

[12]  H. F. E. Morreale.  Polycystic ovary syndrome: treatment strategies and management , 2008 .

[13]  F. Stanczyk,et al.  Ovarian androgen production in postmenopausal women. , 2007, The Journal of clinical endocrinology and metabolism.

[14]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[15]  Jubilee Brown,et al.  The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. , 2005, Gynecologic oncology.

[16]  R. Reznek,et al.  Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women? , 2003, Clinical endocrinology.

[17]  S. Chew,et al.  The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. , 2003, The Journal of clinical endocrinology and metabolism.

[18]  S. Berga,et al.  Postmenopausal Hyperthecosis: Functional Dysregulation of Androgenesis in Climacteric Ovary , 2002, Obstetrics and gynecology.

[19]  J. Barth,et al.  Ovarian hyperthecosis, diabetes and hirsuties in post‐menopausal women , 1997, Clinical endocrinology.

[20]  M. Nagamani,et al.  Hyperinsulinemia in hyperthecosis of the ovaries. , 1986, American journal of obstetrics and gynecology.

[21]  N. Kayani,et al.  Ovarian sex cord stromal tumours in children and young girls - a more than two decade clinicopathological experience in a developing country, Pakistan. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[22]  R. Azziz,et al.  Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study. , 1999, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[23]  H. Sakamoto,et al.  [Ovarian hyperthecosis]. , 1993, Ryoikibetsu shokogun shirizu.